Q4 2025 · 13F-HR
Bruce & Co., Inc.holdings as filed
Filed 2026-02-13 · accession 0001104659-26-015254
$322.5M
Reported value
39
Positions
2025-12-31
Period end
The Brief · Bruce & Co., Inc. · Q4 2025
AI · grounded in 13F
Bruce & Co., Inc. reduced its position in KOD by 40.93%. The fund also trimmed its holdings in Bausch Health by 27.49% and DAR by 19.08%. Overall, the fund reduced eight positions and added no new ones, ending the period with $322.53M in total assets under management.
Holdings as filed
| CUSIP | Ticker | Issuer | Value | % port. | Shares | Class | Voting |
|---|---|---|---|---|---|---|---|
| 00287Y109 | ABBV | Abbvie | $28.0M | 8.68% | 122,500 | Common | SOLE |
| N00985106 | AER | AerCap Holdings | $26.4M | 8.18% | 183,500 | Common | SOLE |
| 020002101 | ALL | Allstate | $26.1M | 8.10% | 125,500 | Common | SOLE |
| 302571104 | — | Nextera Energy | $24.9M | 7.72% | 310,300 | Common | SOLE |
| 023586506 | UHAL/B | Uhaul B | $21.1M | 6.55% | 452,000 | Common | SOLE |
| 589331107 | — | Merck | $20.3M | 6.29% | 192,800 | Common | SOLE |
| 26441C204 | DUK | Duke Energy | $18.3M | 5.66% | 155,816 | Common | SOLE |
| 98389B100 | XEL | XCEL Energy | $14.4M | 4.45% | 194,500 | Common | SOLE |
| 002824100 | ABT | Abbott | $14.3M | 4.42% | 113,800 | Common | SOLE |
| 00206R102 | T | AT & T | $13.0M | 4.03% | 523,000 | Common | SOLE |
| 125896100 | CMS | CMS Energy | $10.9M | 3.38% | 156,000 | Common | SOLE |
| 45774W108 | IIIN | Insteel | $10.9M | 3.37% | 343,423 | Common | SOLE |
| 037833100 | AAPL | Apple | $10.6M | 3.28% | 38,900 | Common | SOLE |
| 651639106 | NEM | Newmont | $10.0M | 3.10% | 100,000 | Common | SOLE |
| 925815102 | VICR | Vicor | $9.9M | 3.06% | 90,000 | Common | SOLE |
| 05379B107 | AVA | Avista | $7.8M | 2.41% | 201,500 | Common | SOLE |
| 717081103 | PFE | Pfizer | $6.8M | 2.10% | 271,900 | Common | SOLE |
| H11356104 | BG | Bunge | $6.2M | 1.93% | 70,000 | Common | SOLE |
| 039483102 | ADM | Archer Daniels | $5.7M | 1.78% | 100,000 | Common | SOLE |
| 50015M109 | KOD | Kodiak Sciences | $4.6M | 1.43% | 165,000 | Common | SOLE |
| 868459108 | SUPN | Supernus | $4.1M | 1.27% | 82,105 | Common | SOLE |
| 237266101 | DAR | Darling Ingredients | $3.8M | 1.18% | 106,000 | Common | SOLE |
| 023586100 | UHAL | Uhaul | $3.7M | 1.16% | 73,900 | Common | SOLE |
| 163851108 | CC | Chemours | $2.9M | 0.91% | 250,000 | Common | SOLE |
| 749607107 | RLI | RLI | $2.6M | 0.81% | 40,800 | Common | SOLE |
| N53745100 | LYB | Lyondellbasell | $2.6M | 0.81% | 60,000 | Common | SOLE |
| 532457108 | LLY | Eli Lilly | $2.1M | 0.67% | 2,000 | Common | SOLE |
| 71535D106 | PSNL | Personalis | $1.9M | 0.58% | 233,000 | Common | SOLE |
| 268311107 | EDAP | EDAP | $1.4M | 0.45% | 438,652 | Common | SOLE |
| 82968B103 | SIRIEUR | XM Sirius | $1.1M | 0.35% | 55,784 | Common | SOLE |
| 56400P706 | MNKD | Mannkind | $1.1M | 0.34% | 195,073 | Common | SOLE |
| 044209104 | — | Ashland | $880,050 | 0.27% | 15,000 | Common | SOLE |
| 91911K102 | — | Bausch Health | $861,800 | 0.27% | 124,000 | Common | SOLE |
| 92556V106 | VTRS | Viatris | $725,574 | 0.22% | 58,279 | Common | SOLE |
| 31189P102 | FATE | Fate Theraputics | $716,500 | 0.22% | 729,188 | Common | SOLE |
| 92333F101 | VG | Venture Global | $682,000 | 0.21% | 100,000 | Common | SOLE |
| 92939U106 | WEC | WEC Energy | $416,040 | 0.13% | 3,945 | Common | SOLE |
| 142038108 | CRBU | Caribou Biosciences | $397,500 | 0.12% | 250,000 | Common | SOLE |
| 65443P102 | MASS | 908 Devices | $358,502 | 0.11% | 68,286 | Common | SOLE |
Source: SEC EDGAR · raw 13F holdings as filed. The Class column shows the option type when reported (Put/Call) or Common when the issuer's equity is held directly. 13F discloses long positions only.